137 related articles for article (PubMed ID: 17083460)
1. Clinical efficacy of intravenous administration of marbofloxacin in a Staphylococcus aureus infection in tissue cages in ponies.
Voermans M; van Soest JM; van Duijkeren E; Ensink JM
J Vet Pharmacol Ther; 2006 Dec; 29(6):555-60. PubMed ID: 17083460
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of local administration of ceftiofur in a Staphylococcus aureus infection in tissue cages in ponies.
Bosch G; van Duijkeren E; Bergwerff AA; Rijkenhuizen AB; Ensink JM
J Vet Pharmacol Ther; 2006 Feb; 29(1):31-6. PubMed ID: 16420299
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of marbofloxacin in horses: preliminary analysis.
Peyrou M; Doucet MY; Vrins A; Concordet D; Schneider M; Bousquet-Mélou A
J Vet Pharmacol Ther; 2004 Oct; 27(5):283-8. PubMed ID: 15500564
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration.
Carretero M; Rodríguez C; San Andrés MI; Forés P; de Lucas JJ; Nieto J; Waxman S; San Andrés MD; González F
Equine Vet J; 2002 Jul; 34(4):360-5. PubMed ID: 12117107
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains.
Schneider M; Vallé M; Woehrlé F; Boisramé B
J Dairy Sci; 2004 Jan; 87(1):202-11. PubMed ID: 14765828
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of marbofloxacin in horses.
Bousquet-Melou A; Bernard S; Schneider M; Toutain PL
Equine Vet J; 2002 Jul; 34(4):366-72. PubMed ID: 12117108
[TBL] [Abstract][Full Text] [Related]
7. Single-dose pharmacokinetics of marbofloxacin in Egyptian buffalo (Bubalus bubalis L.) steers.
Goudah A; Abd El-Aty AM; Regmi NL; Shin HC; Shimoda M; Shim JH
Berl Munch Tierarztl Wochenschr; 2007; 120(5-6):215-20. PubMed ID: 17555042
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of prophylactic administration of trimethoprim/sulfadiazine in a Streptococcus equi subsp. zooepidemicus infection model in ponies.
Ensink JM; Bosch G; van Duijkeren E
J Vet Pharmacol Ther; 2005 Feb; 28(1):45-9. PubMed ID: 15720514
[TBL] [Abstract][Full Text] [Related]
9. Single- and multiple-dose pharmacokinetics of marbofloxacin after oral administration to rabbits.
Carpenter JW; Pollock CG; Koch DE; Hunter RP
Am J Vet Res; 2009 Apr; 70(4):522-6. PubMed ID: 19335109
[TBL] [Abstract][Full Text] [Related]
10. Influence of marbofloxacin on the pharmacokinetics and pharmacodynamics of tolfenamic acid in calves.
Sidhu PK; Landoni MF; Lees P
J Vet Pharmacol Ther; 2005 Feb; 28(1):109-19. PubMed ID: 15720523
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves.
Ismail M; El-Kattan YA
Res Vet Sci; 2007 Jun; 82(3):398-404. PubMed ID: 17118414
[TBL] [Abstract][Full Text] [Related]
12. Seven years survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries.
Meunier D; Acar JF; Martel JL; Kroemer S; Vallé M
Int J Antimicrob Agents; 2004 Sep; 24(3):268-78. PubMed ID: 15325431
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of marbofloxacin in blue and gold macaws (Ara ararauna).
Carpenter JW; Hunter RP; Olsen JH; Henry H; Isaza R; Koch DE
Am J Vet Res; 2006 Jun; 67(6):947-50. PubMed ID: 16740085
[TBL] [Abstract][Full Text] [Related]
14. Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis.
Regnier A; Schneider M; Concordet D; Toutain PL
Am J Vet Res; 2008 Mar; 69(3):410-5. PubMed ID: 18312141
[TBL] [Abstract][Full Text] [Related]
15. Mouse mastitis model of infection for antimicrobial compound efficacy studies against intracellular and extracellular forms of Staphylococcus aureus.
Brouillette E; Grondin G; Lefebvre C; Talbot BG; Malouin F
Vet Microbiol; 2004 Aug; 101(4):253-62. PubMed ID: 15261998
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of marbofloxacin in PMMA orthopaedic cement: an in vitro experimental study.
Cariou M; Boulouis HJ; Moissonnier P
Vet Comp Orthop Traumatol; 2006; 19(2):106-9. PubMed ID: 16810353
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic FIV infection, and efficacy of marbofloxacin treatment, on Mycoplasma haemofelis infection.
Tasker S; Caney SM; Day MJ; Dean RS; Helps CR; Knowles TG; Lait PJ; Pinches MD; Gruffydd-Jones TJ
Vet Microbiol; 2006 Oct; 117(2-4):169-79. PubMed ID: 16876338
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics and pharmacokinetic/pharmacodynamic evaluation of marbofloxacin against Coagulase-negative staphylococci, Staphylococcus aureus and Mycoplasma agalactiae pathogens in goats.
Serrano-Rodríguez JM; Fernández-Varón E; Rodríguez CMC; Andrés-Larrea MIS; Rubio-Langre S; de la Fe C; Dova SW; Bhardwaj P; Sidhu PK; Litterio NJ; Lorenzutti AM
Res Vet Sci; 2023 Jun; 159():1-10. PubMed ID: 37060837
[TBL] [Abstract][Full Text] [Related]
19. Impact of short-course quinolone therapy on susceptible and resistant populations of Staphylococcus aureus.
Drusano GL; Liu W; Brown DL; Rice LB; Louie A
J Infect Dis; 2009 Jan; 199(2):219-26. PubMed ID: 19049435
[TBL] [Abstract][Full Text] [Related]
20. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
